Edition:
India

Precision Therapeutics Inc (AIPT.OQ)

AIPT.OQ on NASDAQ Stock Exchange Capital Market

0.89USD
20 Apr 2018
Change (% chg)

$0.00 (+0.45%)
Prev Close
$0.88
Open
$0.88
Day's High
$0.89
Day's Low
$0.86
Volume
5,457
Avg. Vol
102,594
52-wk High
$2.50
52-wk Low
$0.81

Latest Key Developments (Source: Significant Developments)

Precision Therapeutics Announces Record Streamway System Sales In The First Three Months Of 2018
Thursday, 29 Mar 2018 

March 29 (Reuters) - Precision Therapeutics Inc ::PRECISION THERAPEUTICS ANNOUNCES RECORD STREAMWAY® SYSTEM SALES IN THE FIRST THREE MONTHS OF 2018.PRECISION THERAPEUTICS INC - ‍SKYLINE MEDICAL SOLD 16 STREAMWAY SYSTEMS IN Q1 OF 2018​.PRECISION THERAPEUTICS INC - CO CONTINUES TO PROJECT A TOTAL OF 100 STREAMWAY SYSTEM SALES IN 2018​.  Full Article

Skyline Medical Changes Corporate Name To Precision Therapeutics
Thursday, 25 Jan 2018 

Jan 25 (Reuters) - Skyline Medical Inc ::SKYLINE MEDICAL ANNOUNCES CORPORATE NAME CHANGE TO PRECISION THERAPEUTICS.SKYLINE MEDICAL - CO WILL CHANGE TICKER SYMBOL ON NASDAQ TO 'AIPT'.  Full Article

Skyline Medical Says Sold Ten Streamway Systems In 2017
Thursday, 4 Jan 2018 

Jan 3 (Reuters) - Skyline Medical Inc ::SKYLINE MEDICAL INC - COMPANY SOLD TEN STREAMWAY SYSTEMS IN 2017, FIVE OF WHICH WERE SOLD IN FOURTH FISCAL QUARTER OF 2017.SKYLINE MEDICAL INC - A FURTHER SIX STREAMWAY UNITS HAVE BEEN BOOKED FOR SALE IN JANUARY 2018.  Full Article

Skyline Medical And Helomics Expand Into Next Generation Sequencing For Personalized Medicine
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Helomics Corp ::SKYLINE MEDICAL AND HELOMICS EXPAND INTO NEXT GENERATION SEQUENCING FOR PERSONALIZED MEDICINE.SKYLINE MEDICAL INC - EXPANDING INTO NEXT GENERATION SEQUENCING THROUGH LICENSING OF AN NGS PLATFORM MISEQDX, FROM ILLUMINA.SKYLINE MEDICAL INC - "WE FULLY EXPECT NGS PLATFORM TO DRIVE REVENUE FROM NEW PARTNERSHIPS EARLY IN 2018".  Full Article

Skyline Medical Says Acquiring Up To 25 Pct Stake In Helomics
Wednesday, 20 Dec 2017 

Dec 19 (Reuters) - Skyline Medical Inc ::SKYLINE MEDICAL ACQUIRING UP TO 25% EQUITY STAKE IN HELOMICS CORPORATION, A PRECISION DIAGNOSTICS COMPANY.SKYLINE MEDICAL - PURCHASING PREFERRED STOCK CONVERTIBLE INTO 20% OF OUTSTANDING STOCK OF HELOMICS FOR 1.1 MILLION SHARES OF NEWLY ISSUED CO'S STOCK.  Full Article

Skyline Medical Files For Resale Of Up To 1.9 Mln Shares By Selling Stockholder
Saturday, 9 Dec 2017 

Dec 8 (Reuters) - Skyline Medical Inc ::SKYLINE MEDICAL INC FILES FOR RESALE OF UP TO 1.9 MILLION SHARES OF CO'S COMMON STOCK BY THE SELLING STOCKHOLDER - SEC FILING.  Full Article

Skyline Medical and Helomics Announce Joint Strategic Partnership With GLG Pharma
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Helomics Corp ::SKYLINE MEDICAL AND HELOMICS ANNOUNCE A JOINT STRATEGIC PARTNERSHIP WITH GLG PHARMA.SKYLINE MEDICAL - ‍NEW PARTNERSHIP TO FILE FOR EUROPEAN GRANT APPLICATION TO EXPAND GLG'S AND SKYLINE-HELOMICS VENTURE'S PRODUCT OFFERING​ ACROSS EUROPE.  Full Article

Skyline Medical, Helomics Corp sign joint venture to commercialize D-CHIP platform
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Helomics Corp :Skyline Medical and Helomics Corporation sign joint venture term sheet to build-out and commercialize the D-CHIP platform.Skyline Medical Inc - ‍joint venture is subject to terms and conditions, including further due diligence and financing of new entity​.Skyline Medical Inc - ‍signed a term sheet with Helomics Corporation​.Skyline Medical Inc - ‍deal to leverage Helomics D-CHIP platform to develop and market new approaches for personalized cancer diagnosis and care​.Skyline Medical Inc - ‍skyline Medical will own 51 pct of joint venture, with Helomics owning remaining 49 pct​.Skyline Medical Inc - operations of JV will be managed by Helomics subject to direction and oversight of joint venture's board of directors​.  Full Article

Skyline Medical reports Q3 loss per share $0.16
Wednesday, 15 Nov 2017 

Nov 14 (Reuters) - Skyline Medical Inc :Skyline Medical reports 2017 third quarter financial results.Q3 loss per share $0.16.Q3 revenue $152,500 versus $134,600.  Full Article

Skyline Medical partners with Device Technologies
Friday, 10 Nov 2017 

Nov 9 (Reuters) - Skyline Medical Inc ::Says ‍has partnered with Device Technologies to market STREAMWAY System in Australia, New Zealand, Fiji and Pacific Islands​.  Full Article

BRIEF-Precision Therapeutics Q4 Loss Per Share $0.43

* PRECISION THERAPEUTICS REPORTS FISCAL YEAR 2017 FINANCIAL RESULTS

No consensus analysis data available.